Financial statements - GSK

The Group financial statements for the year ended . 31 December 2020, comprising principal statements and supporting notes, are set out in the ‘Financial statements’ on pages 154 to 237 of this report. The parent company financial statements for the year ended 31 December 2020, comprising the balance sheet and the statement of changes in

  Testament, Financial, Financial statements

Press release Full year and fourth quarter 2020 - GSK

* Reported AER and CER growth rates for 2020 include five months’ results of the former Pfizer consumer healthcare business in 2019. Pro-forma CER growth rates are calculated as if the equivalent seven months of Pfizer consumer healthcare business results, as reported by Pfizer, were included in the comparative period of 2019.

  Pfizer

Annual Report 2020 - GSK

framework, we invest in our business to provide shareholder returns. In 2020 we paid a dividend of 80p per share and delivered £5.4 billion of free cash flow. We make a positive contribution to the communities in . which we operate. We employ over 94,000 people across 96 countries and work directly with 36,000 suppliers.

  Annual, Report, Return, 2200, Shareholders, 2002 annual report, Shareholder returns

Q3 2021 results

Progressing towards demerger at pace. 8. 1. All outlook and ambition statements are given on a constant currency basis and use 2021 forecast exchange rates as a base, assuming a continuation of Q1 2021 closing rates. 2021-26 CAGR is for the 5 …

Annual Report 2019 - GSK

Trust We are a responsible company and commit to use our science and technology to address health needs, make our products affordable and available and to be a modern employer. Our values and expectations Our values – patient focus, transparency, respect and integrity. Our expectations – courage, accountability, development and teamwork.

  Trust, Annual, Report, Annual report, Affordable

Press release Second quarter 2021

All expectations, guidance and targets regarding future performance and dividend payments should be read together with ‘Outlook, assumptions and cautionary statements’ on pages 68 and 69. If exchange rates were to hold at the closing rates on 30 June 2021 ($1.39/£1, €1.17/£1 and Yen 153/£1) for the rest of 2021, the

  Dividend, And dividends

Emma Walmsley, CEO - gsk.com

Agenda 2 Q2 2018 progress (15 mins) Emma Walmsley, Chief Executive Officer Q2 2018 financial results (15 mins) Simon Dingemans, Chief Financial Officer

  Mame

Audit & Risk Committee Terms of Reference - Home | GSK

Audit & Risk Committee – Terms of Reference 2 3. Each of the members of the Committee shall be independent Non-Executive Directors, as determined by the Board of the Company, in accordance with the provisions of the UK Corporate

  Terms, Risks, Reference, Committees, Audit, Terms of reference audit amp risk committee

Press release Third quarter 2021

Issued: Wednesday, 27 October 2021, London, U.K. 3 Operating performance – Q3 2021 Turnover Q3 2021 £m Growth £% Growth CER% Pharmaceuticals 4,397 5 10 Vaccines 2,174 7 13 Consumer Healthcare 2,506 3 8 Group turnover 9,077 5 10 Group turnover was £9,077 million in the quarter, up 5% AER, 10% CER.

  October, 27 october

Annual Report 2018 - GSK

GSK Annual Report 2018 02. Research & development . Success in R&D will always be fundamental to shareholder returns. A renewed focus on R&D was set out by Emma Walmsley when she became CEO in 2017, and a new plan to improve the pipeline of new medicines has now been launched by Dr Hal Barron, our new Chief

  Annual, Report, 2018, 2018 annual report, Gsk annual report 2018

Commonwealth Modern Slavery Statement 2020–21

The Commonwealth Modern Slavery Statement 2020–21 is dedicated to the people and organisations who work tirelessly to prevent modern slavery, and support victims and survivors of modern slavery seeking to rebuild their lives. Acknowledgement of Country The Australian Government acknowledges the traditional

  Testament, Modern, Slavery, 2200, Modern slavery, Modern slavery statement 2020 21

Barclays Group Statement on Modern Slavery

1 This statement is a joint statement made according to the requirements of section 54 of the Modern Slavery Act 2015 or the Australian Commonwealth Modern Slavery Act 2018 for the financial year ending 31 December 2020. This is our fifth …

  Testament, Modern, Slavery, 2200, Modern slavery

Modern Slavery Airbus SE Modern Slavery Statement

Dec 31, 2020 · Modern Slavery Statement Year Ending 31 December, 2020 This Statement has been published in accordance with the UK’s ‘Modern Slavery Act 2015’ and the Australian ‘Modern Slavery Act 2018 (Cth)’. It sets out the steps taken by Airbus SE during the financial year ending 31 December 2020 to prevent modern slavery and

  Testament, Modern, Slavery, 2200, Modern slavery, Modern slavery statement

2020 UK annual report on modern slavery - GOV.UK

Modern Slavery Statement. This outlines the steps undertaken to drive responsible practices and prevent risks in Government supply chains. ... (2020/21) under the new Modern Slavery and Organised Immigration Crime Programme. This investment will enable the police to

  Annual, Report, Testament, Modern, Slavery, 2200, Modern slavery, Modern slavery statement, Annual report on modern slavery

2020-21 Corporate Responsibility Report

the Intel Statement on Combating Modern Slavery, and the UN Guiding Principles on Business and Human Rights. Through our leadership role in the RBA, we drove multiple recommendations to strengthen and clarify the RBA Code of Conduct 7.0 for the triennial update that was released in January 2021. For more, read our RBA Commitment Letter.

  Testament, Modern, Slavery, 2200, Modern slavery